AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03255486 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood samples will be taken by venipuncture during the initial assessment (4 tubes of 5 ml at diagnosis and 3 tubes of 5 ml to the following) These blood tests will be repeated after the first course, at the end of neoadjuvant chemotherapy and after surgery and will be carried out jointly to levies motivated by the balance sheet or the treatment of CS to avoid additional puncture.~These samples will allow us to study the profiles of circulating tumor DNA, and miRNA tumor proteins (proteomics study).
Study NCT04106986 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field and Progressives resistance exercise
Description: The pulsed electromagnetic field treatment consist of 30 minutes pulsed electromagnetic field with 50 Hz pulses~The progressive resistance exercise training consist of 45 minutes of progressive resistance exercise protocol as the following:~The PRE session begun with warm-up exercises that included riding a stationary ergometer for 5 minutes followed by stretching exercises for the hamstrings, quadriceps and gastrocnemius muscles. After this, subjects performed non-weight bearing (open chain) and weight bearing (closed chain) quadriceps exercises.~The amount of resistance and number of repetitions for each exercise are based on a modification of the daily adjustable progressive resistance exercise (DAPRE) program that was described by Knight eta al.
Study NCT04106986 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRE
Description: The progressive resistance exercise training consist of 45 minutes of progressive resistance exercise protocol as the following:~The PRE session begun with warm-up exercises that included riding a stationary ergometer for 5 minutes followed by stretching exercises for the hamstrings, quadriceps and gastrocnemius muscles. After this, subjects performed non-weight bearing (open chain) and weight bearing (closed chain) quadriceps exercises.~The amount of resistance and number of repetitions for each exercise are based on a modification of the daily adjustable progressive resistance exercise (DAPRE) program that was described by Knight eta al.
Study NCT01744990 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Oral food challenges to multiple nuts
Study NCT02260050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WAL 801 CL dry syrup new formulation
Study NCT02260050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: WAL 801 CL dry syrup conventional formulation
Study NCT00815945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PegLiposomal Doxorubicin
Description: PegLiposomal Doxorubicin, intravenous, 40mg/m², every 28 days for up to 6 months
Study NCT00815945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin, intravenous, AUC 6, every 28 days for up to 6 months
Study NCT00411645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: maribavir
Description: 100 mg twice daily for up to 12 weeks
Study NCT00411645 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: twice daily for up to 12 weeks
Study NCT04469920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar Magnesium 2 mg
Description: 1 tablet, single dose at Day 1
Study NCT02326753 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: No. 7 oral airway
Description: the use of 7 cm sized-oropharyngeal airway (Guedel-type color coded oropharyngeal airway, Hudson RCI, Teleflex Medical, Research Triangle Park, NC)
Study NCT02326753 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: No. 8 oral airway
Description: the use of 8 cm sized-oropharyngeal airway (Guedel-type color coded oropharyngeal airway, Hudson RCI, Teleflex Medical, Research Triangle Park, NC)
Study NCT02326753 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: No. 9 oral airway
Description: the use of 9 cm sized-oropharyngeal airway (Guedel-type color coded oropharyngeal airway, Hudson RCI, Teleflex Medical, Research Triangle Park, NC)
Study NCT02956265 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bimodal optical spectroscopy
Description: an optical fiber will be put in gentle contact with the patient's skin in order to acquire optical spectra
Study NCT04469920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar Magnesium 4 mg
Description: 1 tablet, single dose at Day 1
Study NCT03839485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Endodontic treatment using Guedes-Pinto Paste
Description: Dental procedure in which the entire pulp chamber is removed from the crown and roots of a tooth and the root filling material Guedes-Pinto paste is applied
Study NCT03839485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endodontic using Guedes-Pinto Paste without antibiotic
Description: Dental procedure in which the entire pulp chamber is removed from the crown and roots of a tooth and the root filling material Guedes-Pinto paste without antibiotic is applied
Study NCT02743806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Description: Vedolizumab IV infusion
Study NCT02615587 — intervention group
Intervention type: DRUG
Intervention: Standard of care in AF in Denmark
Description: As used in clinical practice, analysed as per drug class, not separate drugs.
Study NCT00597545 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Carotid endarterectomy
Description: When a shunt is inserted to increase blood flow to the brain
Study NCT00597545 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Description: When a shunt is inserted to increase blood flow to the brain
Study NCT00597545 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Shunt
Description: A tube inserted below and above the surgical area at the time when the carotid artery is clamped to allow the surgeon to work in a bloodless field and to supplement blood flow to the brain.
Study NCT00597545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shunt
Description: A tube inserted below and above the surgical area at the time when the carotid artery is clamped to allow the surgeon to work in a bloodless field and to supplement blood flow to the brain.
Study NCT00111592 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: current usual care
Description: current usual care
Study NCT00111592 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: treatment protocol with clear indications for therapy
Description: treatment protocol with clear indications for therapy
Study NCT02514447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Study NCT04140695 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tradipitant
Description: BID
Study NCT04140695 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: BID
Study NCT04463199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Craniocervical flexion training
Description: PBU airbag was clipped together and folded in, fastened, and placed suboccipital. Uninflated pressure sensor was kept below the neck, so that it touched the occiput then inflated to a stable baseline pressure of 20 mmHg to just fill the space below the neck but not to push it into lordosis. Subjects were demonstrated the correct action of the deep cervical flexors that is gentle nodding of head as if saying yes.
Study NCT01559259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen/acetaminophen
Description: Two caplets of ibuprofen 100 mg plus acetaminophen 250 mg
Study NCT01559259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen/acetaminophen
Description: Two caplets of ibuprofen 125 mg plus acetaminophen 250 mg
Study NCT01559259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen/acetaminophen
Description: Two caplets of ibuprofen 150 mg plus acetaminophen 250 mg
Study NCT01559259 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Two caplets of ibuprofen 200 mg
Study NCT01559259 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two caplets of placebo
Study NCT04165941 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DRI cell therapy
Description: Drug Resistant Immunotherapy with gamma delta modified T cells to be resistance to temozolomide will be infused into the surgical cavity following the completion of standard concurrent radiation and chemotherapy with temozolomide.
Study NCT04098432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 3 mg/kg intravenously every two weeks untill disease progression or unacceptable toxicity
Study NCT04098432 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy
Description: The prescribed dose will be 32 Gy in four fractions in four weeks (8 Gy per one fraction).
Study NCT02616926 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hepatic resection
Description: Anatomical surgical resection of the liver including the tumor. Make sure the resection margin is negative during the process.
Study NCT04178252 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mask
Description: investigators will add eye mask to standard treatment
Study NCT02514447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02616926 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TACE
Description: TACE will be performed according to the standard procedure of TACE and will be repeated every four months if needed
Study NCT02616926 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RFA
Description: RFA will be performed 1 week after TACE.
Study NCT03528603 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oleocanthal-Rich Extra Virgin Olive Oil
Description: Extra Virgin Olive Oil that contains a high level of the phenolic oleocanthal
Study NCT03528603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oleocanthal-Rich Extra Virgin Olive Oil
Description: Extra Virgin Olive Oil that contains a high level of the phenolic oleocanthal
Study NCT03528603 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oleocanthal-low Extra Virgin Olive Oil
Description: Extra Virgin Olive Oil that contains a low level of the phenolic oleocanthal
Study NCT03528603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oleocanthal-low Extra Virgin Olive Oil
Description: Extra Virgin Olive Oil that contains a low level of the phenolic oleocanthal
Study NCT02219659 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sedation Protocol with Daily Interruption
Description: Continuous infusion of fentanyl and midazolam is started and titrated to target pain and RASS score: Fentanyl started at 25 mcg/hr titrated by 25 mcg/hr every 30 minutes to goal pain score; Midazolam started at 1 mg/hr titrated by 1 mg/hr every hour to goal RASS score for the study design duration (28 days) or for the duration of mechanical ventilation. Every morning both infusions are stopped and when the patient is awake and met the SBT safety screen, 120-min CPAP trial is performed. If the patient meets the CPAP passing criteria, arterial blood gas (ABG) is done and the patient is placed back to the previous ventilator setting. ABG result is notified to the physician for determination for extubation. If the patient does not pass the CPAP trial it is repeated next morning.
Study NCT02219659 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sedation Protocol Without Daily Interruption
Description: Continuous infusion of fentanyl and midazolam is started and titrated to target pain and RASS score: Fentanyl started at 25 mcg/hr titrated by 25 mcg/hr every 30 minutes to goal pain score; Midazolam started at 1 mg/hr titrated by 1 mg/hr every hour to goal RASS score for the study design duration (28 days) or for the duration of mechanical ventilation. Every morning when the patient's RASS score is 0 to -2 and the patient passes the SBT safety screen, 120-min CPAP trial is performed. If the patient meets the CPAP passing criteria, arterial blood gas (ABG) is done and the patient is placed back to the previous ventilator setting. ABG result is notified to the physician for determination for extubation. If the patient does not pass the CPAP trial it is repeated next morning.
Study NCT02219659 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Push First
Description: Fentanyl 25 mcg intravenous push (IVP) every 5 min up to 4 doses hourly as needed to target pain score for the study design duration (28 days) or for the duration of mechanical ventilation. Every morning when patient's RASS is 0 to -2 and passes the SBT safety screen, 120-min CPAP trial is performed. If patient meets CPAP passing criteria, the physician will be notified for determination of extubation. If patient does not pass, it is repeated next morning. If target RASS is not achieved with fentanyl IV push alone, study team is notified and fentanyl infusion at 50 mcg/hr titrated by 25 mcg/hr every 30 min to target pain score (max 6 hrs). If target RASS score is not achieved with the fentanyl IV, propofol infusion is started at 5 mcg/kg/hr titrated by 5 mcg/kg/hr every 15 min to target RASS score (max 6 hrs).
Study NCT05144659 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Double faced transverse preputial onlay island flap
Description: A well-established one-stage repair of penile hypospadias called Double faced transverse preputial onlay island flap
Study NCT04178252 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: headset
Description: investigators will add headset to standard treatment
Study NCT05144659 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transverse inner preputial onlay island flap
Description: A second well-established one-stage repair of penile hypospadias called Transverse inner preputial onlay island flap
Study NCT02265354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collective-Intelligence computer tailored health communication
Study NCT02265354 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rule-based computer tailored health communication
Study NCT04178252 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard drug
Description: investigators will use 10 mg metoclopramide in 150 ml saline given IV over 10 minutes
Study NCT04188418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Citrate Buccal Tablet
Description: Given transmucosally
Study NCT04188418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Given PO
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Performance Testing
Description: Complete shuttle walk test
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Performance Testing
Description: Complete shuttle walk test
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04188418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02845479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrative Care
Description: Standardized supplemental/natural health product, physical, nutritional and mental/emotional recommendations based on the phases of standard care (neo-adjuvant, perioperative, adjuvant and long-term maintenance).
Study NCT03842969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7234292 (RG6042)
Description: Intrathecal injection
Study NCT04433689 — intervention group
Intervention type: DEVICE
Intervention: Non-Contact measurement of corneal properties
Description: Corneal Properties will be measurement with the non-contact Corvis ST Air-Puff Tonometer by Oculus Inc.
Study NCT01159171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: 5 mg/kg intravenously every 14 days
Study NCT01159171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine [Xeloda]
Description: 1000 mg/m2 orally b.i.d. , Days 1 - 14 of every 28-day cycle
Study NCT01159171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: 40 mg/m2 iv weekly
Study NCT00121524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Epinephrine 1 mg is given iv. every 3 min during CPR
Study NCT00121524 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravenous needle
Description: An intravenous needle in placed as soon as possible during CPR
Study NCT00121524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine
Description: Atropine 3 mg iv in initial systole
Study NCT00121524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone
Description: amiodarone 300 mg iv after repeated failed defibrillation attempts
Study NCT03193723 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: US guided five step field block
Description: Ultrasound will guide needle insertion in the following layers (except intradermic injection):~* Subdermic infiltration. Approximately 8 milliliters~* Intradermic injection (making of the skin wheal). of approximately 6 milliliters.~* Deep subcutaneous injection. 8 milliliters of the mixture will be injected deep into the subcutaneous adipose~* Subfascial infiltration. Approximately eight milliliters of the anesthetic mixture will be injected immediately underneath the aponeurosis of the external oblique.~* Pubic tubercle and hernia sac injection. Occasionally, infiltration of ten milliliters of the mixture at the level of the pubic tubercle, around the neck and inside the indirect hernia sac
Study NCT03193723 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal anesthesia
Description: Spinal anesthesia will be administered in sitting position, with 25 gauge Quincke spinal needle in L3-L4 intervertebral space, under all aseptic precautions and local infiltration, with 3.0 ml of 0.5% bupivacaine (heavy) after ensuring free, clear and adequate flow of cerebrospinal fluid. After giving spinal anesthesia, patient will be made to lie supine.
Study NCT05037448 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Me & My Wishes
Description: Me \& My Wishes videos communicate residents' preferences via personalized video recorded conversations. Me \& My Wishes are videos of nursing home residents talking about their preferences for care, and include four sections: About Me, Preferences for Today, Preferences for Medical Intervention and End of Life, and Afterthoughts.
Study NCT04484896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gain-framed SMS message
Description: Emergency recruitment cell phone short messages that emphasizing donating blood can save patients' lives were sent to donors in this group.
Study NCT04484896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Loss-framed SMS message
Description: Emergency recruitment cell phone short messages emphasizing that donating blood can prevent patients from death were sent to donors in this group.
Study NCT04484896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information SMS message
Description: Emergency recruitment cell phone short messages that only mentioning the low Rh-negative blood stockpile were sent to donors in this group.
Study NCT01416103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention group
Description: Alcohol treatment paralleling welfare-to-work participation: The participants are referred to the municipalities' outpatient alcohol treatment programmes and at the same time referred to an ordinary welfare-to-work programme.
Study NCT01416103 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: The participants will as usual be referred to the welfare-to-work schemes deemed most appropriate by the caseworker. The intervention is no different than what the municipality would have offered if the participant was not part of the study.
Study NCT02502227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness
Description: Mindfulness training practices aim to foster attention and acceptance toward one's present moment experience. Mindfulness consists of two components-- (1) deploying attention to monitor one's moment-to-moment experience, and (2) fostering an attitude of acceptance toward one's moment-to-moment experience
Study NCT01704729 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: group1
Description: Non-cycloplegic self-refraction +conventional glasses
Study NCT01704729 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: group2
Description: Cycloplegic subjective refraction by experienced optometrist +conventional glasses
Study NCT01704729 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: group3
Description: Cycloplegic subjective refraction by Rural Refractionist Program + conventional glasses
Study NCT01704729 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: group4
Description: Cycloplegic subjective refraction by an experienced optometrist +ready-made glasses